Cirsium Biosciences

cirsiumbio.com

Cirsium Biosciences is revolutionizing the gene therapy industry by developing innovative viral vector production methods using whole plants as bioreactors. Their platform addresses significant manufacturing challenges such as scalability, cost, and lead times, achieving up to a 70% reduction in manufacturing lead times for gene therapies. By utilizing a non-GMP controlled environment, they offer a cost-effective solution that simplifies the supply chain and enhances safety. With a commitment to improving global access to life-saving therapies, Cirsium is positioned as a leader in the gene therapy market, leveraging their unique plant-based production technology to meet the growing demand for viral vectors.